BACKGROUND AND OBJECTIVES: Hypertension is an important cause of chronic kidney disease (CKD). Identifying risk factors for progression to CKD in patients with normal kidney function and hypertension may help target therapies to slow or prevent decline of kidney function. Our objective was to identify risk factors for development of incident CKD and decline in estimated GFR (eGFR) in hypertensive patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Cox proportional hazards models were used to assess the relationship between incident CKD (defined as eGFR <60 ml/min per 1.73 m(2)) and potential risk factors for CKD from a registry of hypertensive patients. RESULTS: Of 43,305 patients meeting the inclusion criteria, 12.1% (5236 patients) developed incident CKD. Diabetes was the strongest predictor of incident CKD (hazard ratio, 1.96; 95% confidence interval, 1.84 to 2.09) and was associated with the greatest rate of decline in eGFR (-2.2 ml/min per 1.73 m(2) per year). Time-varying systolic BP was associated with incident CKD with risk increasing above 120 mmHg; each 10-mmHg increase in baseline and time-varying systolic BP was associated with a 6% increase in the risk of developing CKD (hazard ratio, 1.06; 95% confidence interval, 1.04 to 1.08 for both). Time-weighted systolic BP was associated with a more rapid decline in eGFR of an additional 0.2 ml/min per 1.73 m(2) per year decline for every 10-mmHg increase in systolic BP. CONCLUSIONS: We found that time-varying systolic BP was associated with incident CKD, with an increase in risk above a systolic BP of 120 mmHg among individuals with hypertension.
BACKGROUND AND OBJECTIVES:Hypertension is an important cause of chronic kidney disease (CKD). Identifying risk factors for progression to CKD in patients with normal kidney function and hypertension may help target therapies to slow or prevent decline of kidney function. Our objective was to identify risk factors for development of incident CKD and decline in estimated GFR (eGFR) in hypertensivepatients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Cox proportional hazards models were used to assess the relationship between incident CKD (defined as eGFR <60 ml/min per 1.73 m(2)) and potential risk factors for CKD from a registry of hypertensivepatients. RESULTS: Of 43,305 patients meeting the inclusion criteria, 12.1% (5236 patients) developed incident CKD. Diabetes was the strongest predictor of incident CKD (hazard ratio, 1.96; 95% confidence interval, 1.84 to 2.09) and was associated with the greatest rate of decline in eGFR (-2.2 ml/min per 1.73 m(2) per year). Time-varying systolic BP was associated with incident CKD with risk increasing above 120 mmHg; each 10-mmHg increase in baseline and time-varying systolic BP was associated with a 6% increase in the risk of developing CKD (hazard ratio, 1.06; 95% confidence interval, 1.04 to 1.08 for both). Time-weighted systolic BP was associated with a more rapid decline in eGFR of an additional 0.2 ml/min per 1.73 m(2) per year decline for every 10-mmHg increase in systolic BP. CONCLUSIONS: We found that time-varying systolic BP was associated with incident CKD, with an increase in risk above a systolic BP of 120 mmHg among individuals with hypertension.
Authors: William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi Journal: N Engl J Med Date: 2010-03-14 Impact factor: 91.245
Authors: Suma Vupputuri; Vecihi Batuman; Paul Muntner; Lydia A Bazzano; John J Lefante; Paul K Whelton; Jiang He Journal: Hypertension Date: 2003-11-03 Impact factor: 10.190
Authors: Caroline S Fox; Martin G Larson; Eric P Leip; Bruce Culleton; Peter W F Wilson; Daniel Levy Journal: JAMA Date: 2004-02-18 Impact factor: 56.272
Authors: Melanie K Haroun; Bernard G Jaar; Sandra C Hoffman; George W Comstock; Michael J Klag; Josef Coresh Journal: J Am Soc Nephrol Date: 2003-11 Impact factor: 10.121
Authors: Joe V Selby; Tiffany Peng; Andrew J Karter; Mark Alexander; Stephen Sidney; Jean Lian; Amy Arnold; Dan Pettitt Journal: Am J Manag Care Date: 2004-02 Impact factor: 2.229
Authors: Tazeen H Jafar; Paul C Stark; Christopher H Schmid; Marcia Landa; Giuseppe Maschio; Paul E de Jong; Dick de Zeeuw; Shahnaz Shahinfar; Robert Toto; Andrew S Levey Journal: Ann Intern Med Date: 2003-08-19 Impact factor: 25.391
Authors: Peter Janssens; Karen Van Hoeve; Liesbeth De Waele; Stéphanie De Rechter; Kathleen J Claes; Els Van de Perre; Karl Martin Wissing; Bert Bammens; Anna Jansen; Djalila Mekahli Journal: Pediatr Nephrol Date: 2018-07-09 Impact factor: 3.714
Authors: Stacie L Daugherty; Frederick A Masoudi; Chan Zeng; P Michael Ho; Karen L Margolis; Patrick J O'Connor; Alan S Go; David J Magid Journal: J Hypertens Date: 2013-02 Impact factor: 4.844
Authors: Farrukh M Koraishy; Steven G Coca; Beth E Cohen; Jeffery F Scherrer; Frank Mann; Pei-Fen Kuan; Benjamin J Luft; Sean A P Clouston Journal: Psychosom Med Date: 2021 Nov-Dec 01 Impact factor: 4.312